1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEds Accelerator Award (American Cancer Society) is sponsored by American Cancer Society. Supports commercialization validation and de‑risking of ongoing cancer research projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
RFA: Extramural Discovery Science Accelerator Award | American Cancer Society https://searchapi. cancer. org Use double-quotes ("") around a phrase for an exact result Our 24/7 cancer helpline provides information and answers for people dealing with cancer.
We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear. Live Chat available weekdays, 7:00 am - 6:30 pm CT Call us at 1-800-227-2345 Available any time of day or night Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat.
We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include: Referrals to patient-related programs or resources Donations, website, or event-related assistance For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science (EDS) Apply for a Research Grant Arizona (AZ) Discovery Boost Grants (DBG) ASTRO-ACS Clinician Scientist Development Grant (CSDG) Clinician Scientist Development Grant (CSDG) Discovery Boost Grants (DBG) HEALED Gold Medal RFA To Support Mind-Body-Spirit Wellness in Cancer Survivors Institutional Research Grants Mission Boost Grants (MBG) RFA: ACS IMPACT - Expanding Prostate Cancer Clinical Trials in the Community RFA: Extramural Discovery Science Accelerator Award RFA: Leukemia Exploration and Prevention Grant Program (LEAP) TheoryLab Collaborative (TLC) Grant RFA: Cancer Health Research Centers (CHERCs) RFA: Biology to Prevention Award (CRUK) RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant RFA: American Cancer Society Catalyst Awards RFA: American Cancer Society - Flatiron Real-World Data Impact Award Extramural Grants Department Staff Contacts Definition of Research Areas FAQs: ACS Extramural Discovery Science and Grant Application Submissions Extramural Priority Research Areas American Cancer Society Research Events EDS: Our Research Programs Career Growth and Research Excellence Program Institutional Research Grants (IRG) Cancer Detection and Experimental Therapeutics (PF-CDET) Cell Biology and Immunology (PF-CBI) Clinical and Population Sciences (PF-CPS) Molecular Biology and Biochemistry (PF-MBB) Biochemistry and Immunology of Cancer Program DNA Mechanisms in Cancer (DMC) PRC Immunology and Blood Cell Development (IBCD) PRC RNA Mechanisms in Cancer (RMC) PRC Tumor Biochemistry and Endocrinology (TBE) PRC Mission Boost Grants (MBG) PRC Cell Biology and Preclinical Cancer Research Program Cancer Cell Biology (CCB) PRC Cancer Detection and Progression (CDP) PRC Experimental Therapeutics (ET) PRC Metastasis and Microenvironment (MM) PRC Clinical and Population Sciences Program Cancer Prevention and Health Promotion (CPHP) PRC Treatment, Palliative Care, and Survivorship Research (CTPS) Etiology, Screening, and Early Detection (ESED) Healthcare Outcomes, Policy, and Systems Research (HOPS) Peer Review Committees (PRCs) Discovery Scientific Council Community Research Partner Participation American Cancer Society Professors Nobel Laureates and the American Cancer Society American Cancer Society-Jiler Professors & Fellows Conference RFA: Extramural Discovery Science Accelerator Award The intent of the Extramural Discovery Science (EDS) Accelerator Award is to support the commercialization of an ongoing cancer research project and to validate and de-risk technologies.
Proposals should address key experiment(s) required to move findings toward commercialization that do not easily fit into traditional grant funding mechanisms. This mechanism is not designed to initiate new projects or develop new directions for an ongoing project.
The proposal should be commercially driven with the PI having a plan to license the technology, either to an established company or a start-up if the experiment(s) are successful.
Examples of research that align with the focus of this funding initiative include but are not limited to : Dosing, toxicity and/or efficacy testing Testing of biopsies or other patient samples to correlate clinical outcome Technologies for healthcare delivery Accelerator awardees will become part of an entrepreneurial collaborative learning community focused on technology commercialization.
Grantees will have access to both educational programming developed by the ACS BrightEdge team and the team itself. We no longer require applicants to be current or former ACS grantees or fellows. Starting in 2025, applicants must: Be an independent investigator with a full-time faculty appointment (or equivalent), at an eligible US institution.
Applicants may be at any career stage. Be motivated to commercialize their technology. Budgets can be up to $75,000 total costs for a one-year term.
Indirect costs are not allowed. Application and Review Process Applications will be accepted on a rolling basis during the year (i.e., no set deadline). Applications submitted through June 1, will be reviewed in July.
Applications submitted after June 1, will be reviewed in December. Grants start in September 2025 (July review) or April 2026 (December review). If the grant application deadline falls on a weekend or holiday, applications will be accepted the following business day.
Application materials are available on ProposalCentral . Applicants will have 1 month from starting the application to submit it in ProposalCentral. Please see the application instructions for detailed guidelines.
Program Contact: Doug Hurst, PhD at doug. hurst@cancer. org EDS Accelerator Award Policies EDS Accelerator Award Instructions Help us end cancer as we know it, for everyone.
According to the current listing, eligibility includes: Independent investigators with full-time faculty appointment at eligible U. S. nonprofit or academic institutions; any career stage; must have a plan to commercialize/license the technology. Confirm the full requirements in the official notice before applying.
The current listing shows $75,000 total costs for one year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Eds Accelerator Award (American Cancer Society) is funded by American Cancer Society. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article